Mapping neurosensory disorders and pain in patients treated for oral cavity and oropharynx cancer
Neurosensorial Disorder and Pain in Oral Cavity and Oropharynx Cancer Traited Patients
This study is trying to understand and track nerve-related issues and pain in patients who have been treated for cancers in the mouth and throat.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Clermont-Ferrand Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Clermont-Ferrand) |
| Trial ID | NCT04673981 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate and map neurosensory disorders such as hypoesthesia and paresthesia in patients who have undergone treatment for cancers of the oral cavity and oropharynx. It involves a detailed assessment during routine follow-up consultations with maxillo-facial surgeons, where patient data, treatment history, and symptoms of peripheral neuropathy are collected. The study also includes diagnostic tests for neuropathic pain and quality of life assessments using standardized questionnaires.
Who should consider this trial
Good fit: Ideal candidates are patients aged 18 and older who have been treated for oral cavity or oropharynx tumors within the last one to five years.
Not a fit: Patients with mental disorders, pregnant or nursing women, and those unable to comply with the protocol may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of neurosensory disorders and pain in cancer survivors, enhancing their quality of life.
How similar studies have performed: While there is limited data on similar studies, the approach of mapping neurosensory disorders in cancer patients is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient treated for an oral cavity and oropharynx tumor from at least one year and maximum five years. * Women or men upper 18 years old) * Patient with full consent, aware and signed * Patient cover by the French social security system Exclusion Criteria: * Patient with mental disorder, psychologic, with a defect of comprehension to agree fully the protocol * Pregnant women or nursing * Patients who can't comply with the protocol * Participation refusal * Inable full age patient or under judicial protection
Where this trial is running
Clermont-Ferrand
- CHU de Clermont-Ferrand — Clermont-Ferrand, France (Recruiting)
Study contacts
- Principal investigator: Nathalie PHAM DANG — University Hospital, Clermont-Ferrand
- Study coordinator: Lise LACLAUTRE
- Email: promo_interne_drci@chu-clermontferrand.fr
- Phone: +33473754963
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.